Fusarium volatile, a new potential pathogen from a human respiratory sample.

Area of Science:

• Medical Mycology
• Fungal Taxonomy
• Antimicrobial Resistance

Background:

• Pulmonary infections can be caused by various fungal pathogens.
• Accurate identification and characterization of fungal species are crucial for effective treatment.
• The Fusarium genus includes species with diverse clinical and ecological roles.

Purpose of the Study:

• To isolate and characterize a novel fungal species from a clinical sample.
• To determine the phylogenetic and morphological distinctiveness of the new species.
• To evaluate the antifungal susceptibility profile of the newly described fungus.

Main Methods:

• Isolation of fungus from bronchoalveolar lavage (BAL) sample.
• Phylogenetic analysis using multiple gene loci (cmdA, tef1, rpb2, tub).
• Morphological characterization and antifungal susceptibility testing.

Main Results:

• A new fungal species, Fusarium volatile, was identified and described.
• Phylogenetic analysis placed the new species within the Fusarium fujikuroi species complex, related to the African clade.
• Fusarium volatile exhibited resistance to echinocandins, fluconazole, and itraconazole, with lower minimum inhibitory concentrations (MICs) for amphotericin B, voriconazole, and posaconazole.

Conclusions:

• Fusarium volatile represents a newly identified fungal taxon with potential clinical significance.
• The distinct phylogenetic and morphological characteristics warrant its classification as a new species.
• The observed antifungal resistance profile highlights the need for careful selection of antifungal agents for treating infections caused by this species.